# Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne

> **NCT01425320** · PHASE1 · WITHDRAWN · sponsor: **Allergan**

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Fixed Combination dapsone/adapalene Formulation A Gel
- **DRUG:** Fixed Combination dapsone/adapalene Formulation B Gel
- **DRUG:** dapsone 5% gel
- **DRUG:** adapalene 0.3% gel

## Key facts

- **NCT ID:** NCT01425320
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was never initiated due to company decision. No study subjects were ever enrolled or dosed.
- **Last updated:** 2012-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01425320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01425320, "Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01425320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*